157 related articles for article (PubMed ID: 37384668)
1. Genetic variants of MUC4 are associated with susceptibility to and mortality of colorectal cancer and exhibit synergistic effects with LDL-C levels.
Kwon MJ; Lee JY; Kim EJ; Ko EJ; Ryu CS; Cho HJ; Jun HH; Kim JW; Kim NK
PLoS One; 2023; 18(6):e0287768. PubMed ID: 37384668
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
Lu S; Catalano C; Huhn S; Pardini B; Partu L; Vymetalkova V; Vodickova L; Levy M; Buchler T; Hemminki K; Vodicka P; Försti A
PLoS One; 2019; 14(5):e0216666. PubMed ID: 31091244
[TBL] [Abstract][Full Text] [Related]
3. Association Study between Mucin 4 (
Kim JH; Park HS; Lee JY; Ko EJ; Kim YR; Cho HY; Lee WS; Ahn EH; Kim NK
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741699
[TBL] [Abstract][Full Text] [Related]
4. Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer.
Pothuraju R; Pai P; Chaudhary S; Siddiqui JA; Cox JL; Kaur S; Rachagani S; Roy HK; Bouvet M; Batra SK
Aging (Albany NY); 2022 Mar; 14(5):2025-2046. PubMed ID: 35255004
[TBL] [Abstract][Full Text] [Related]
5. MUC4 gene polymorphisms associate with endometriosis development and endometriosis-related infertility.
Chang CY; Chang HW; Chen CM; Lin CY; Chen CP; Lai CH; Lin WY; Liu HP; Sheu JJ; Tsai FJ
BMC Med; 2011 Feb; 9():19. PubMed ID: 21349170
[TBL] [Abstract][Full Text] [Related]
6. Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer.
Das S; Rachagani S; Sheinin Y; Smith LM; Gurumurthy CB; Roy HK; Batra SK
Oncogene; 2016 May; 35(20):2645-54. PubMed ID: 26364605
[TBL] [Abstract][Full Text] [Related]
7. Mucin gene polymorphisms are associated with endometriosis in Korean women.
Kim JH; Kim TH; Kim YS; Jang WC; Ryu A; Hwang JY; Lee HH
Arch Gynecol Obstet; 2020 Mar; 301(3):801-807. PubMed ID: 31858233
[TBL] [Abstract][Full Text] [Related]
8. Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers.
Oh HR; An CH; Yoo NJ; Lee SH
Pathol Oncol Res; 2015 Jul; 21(3):713-8. PubMed ID: 25573589
[TBL] [Abstract][Full Text] [Related]
9. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.
Abulí A; Fernández-Rozadilla C; Alonso-Espinaco V; Muñoz J; Gonzalo V; Bessa X; González D; Clofent J; Cubiella J; Morillas JD; Rigau J; Latorre M; Fernández-Bañares F; Peña E; Riestra S; Payá A; Jover R; Xicola RM; Llor X; Carvajal-Carmona L; Villanueva CM; Moreno V; Piqué JM; Carracedo A; Castells A; Andreu M; Ruiz-Ponte C; Castellví-Bel S;
BMC Cancer; 2011 Aug; 11():339. PubMed ID: 21819567
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.
Jonckheere N; Van Seuningen I
J Transl Med; 2018 Sep; 16(1):259. PubMed ID: 30236127
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive assessments of germline deletion structural variants reveal the association between prognostic MUC4 and CEP72 deletions and immune response gene expression in colorectal cancer patients.
Lin PC; Chen HO; Lee CJ; Yeh YM; Shen MR; Chiang JH
Hum Genomics; 2021 Jan; 15(1):3. PubMed ID: 33431054
[TBL] [Abstract][Full Text] [Related]
12. Family-based exome sequencing combined with linkage analyses identifies rare susceptibility variants of MUC4 for gastric cancer.
Choi YJ; Ohn JH; Kim N; Kim W; Park K; Won S; Sael L; Shin CM; Lee SM; Lee S; An HJ; Jang DM; Han BW; Lee HS; Kang SJ; Kim JS; Lee DH
PLoS One; 2020; 15(7):e0236197. PubMed ID: 32701958
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas.
Yokoyama S; Higashi M; Kitamoto S; Oeldorf M; Knippschild U; Kornmann M; Maemura K; Kurahara H; Wiest E; Hamada T; Kitazono I; Goto Y; Tasaki T; Hiraki T; Hatanaka K; Mataki Y; Taguchi H; Hashimoto S; Batra SK; Tanimoto A; Yonezawa S; Hollingsworth MA
Oncotarget; 2016 Jul; 7(27):42553-42565. PubMed ID: 27283771
[TBL] [Abstract][Full Text] [Related]
14. Synergistic induction of the MUC4 mucin gene by interferon-gamma and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways.
Andrianifahanana M; Agrawal A; Singh AP; Moniaux N; van Seuningen I; Aubert JP; Meza J; Batra SK
Oncogene; 2005 Sep; 24(40):6143-54. PubMed ID: 16007204
[TBL] [Abstract][Full Text] [Related]
15. Alternate splicing at the 3'-end of the human pancreatic tumor-associated mucin MUC4 cDNA.
Choudhury A; Moniaux N; Ringel J; King J; Moore E; Aubert JP; Batra SK
Teratog Carcinog Mutagen; 2001; 21(1):83-96. PubMed ID: 11135323
[TBL] [Abstract][Full Text] [Related]
16. Effect of Mucine 4 and Fucosyltransferase 1 genetic variants on gut homoeostasis of growing healthy pigs.
Luise D; Motta V; Bertocchi M; Salvarani C; Clavenzani P; Fanelli F; Pagotto U; Bosi P; Trevisi P
J Anim Physiol Anim Nutr (Berl); 2019 May; 103(3):801-812. PubMed ID: 30734380
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol Enhances Colorectal Cancer Progression via ROS Elevation and MAPK Signaling Pathway Activation.
Wang C; Li P; Xuan J; Zhu C; Liu J; Shan L; Du Q; Ren Y; Ye J
Cell Physiol Biochem; 2017; 42(2):729-742. PubMed ID: 28618417
[TBL] [Abstract][Full Text] [Related]
18. Roles of genetic variants in the PI3K/PTEN pathways in susceptibility to colorectal carcinoma and clinical outcomes treated with FOLFOX regimen.
Lin L; Zhang Z; Zhang W; Wang L; Wang J
Int J Clin Exp Pathol; 2015; 8(10):13314-22. PubMed ID: 26722535
[TBL] [Abstract][Full Text] [Related]
19. Mucin Expression in Colorectal Cancer (CRC): Systematic Review and Meta-Analysis.
Niv Y; Rokkas T
J Clin Gastroenterol; 2019 Jul; 53(6):434-440. PubMed ID: 29782466
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variants of
Kim JO; Jun HH; Kim EJ; Lee JY; Park HS; Ryu CS; Kim S; Oh D; Kim JW; Kim NK
Front Oncol; 2020; 10():72. PubMed ID: 32117729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
